CUSIP 800677106COMSGMOQ4 2025
31 filings · latest Nov 12, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 12.00M | $5.04M |
| 2 | Renaissance Technologies LLC | 8.43M | $3.54M |
| 3 | Two Sigma Investments, LP | 4.76M | $2.00M |
| 4 | Blackrock, Inc. | 4.57M | $1.92M |
| 5 | Two Sigma Advisers, LP | 4.34M | $1.82M |
| 6 | Geode Capital Management, LLC | 3.87M | $1.62M |
| 7 | Jane Street Group, LLC | 2.92M | $1.23M |
| 8 | Susquehanna International Group, LLP | 2.14M | $897.6K |
| 9 |
| 4 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 4.6% | 9.60M | SEC |
| 5 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 4.6% | 9.60M | SEC |
| 6 | Aug 16, 2024 | Biogen Inc. | 13G/A | 1.6% | 3.25M | SEC |
| 7 | Jul 8, 2024 | Blackrock Inc. | 13G/A | 2.3% | 4.70M | SEC |
| 8 | Apr 5, 2024 | Wasatch Advisors LP | 13G/A | 11.9% | — | SEC |
| 9 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 7.1% | 12.60M | SEC |
| 10 | Feb 12, 2024 | Biogen Inc. | 13G/A | 8.3% | 14.65M | SEC |
See the full Schedule 13D/13G history for Sangamo Therapeutics Inc.
Unlock full history| Charles Schwab Investment Management Inc |
| 1.71M |
| $719.6K |
| 10 | Wasatch Advisors LP | 1.42M | $595.0K |